217 related articles for article (PubMed ID: 11250941)
1. Rosiglitazone, insulin treatment, and fasting correct defective activation of protein kinase C-zeta/lambda by insulin in vastus lateralis muscles and adipocytes of diabetic rats.
Kanoh Y; Bandyopadhyay G; Sajan MP; Standaert ML; Farese RV
Endocrinology; 2001 Apr; 142(4):1595-605. PubMed ID: 11250941
[TBL] [Abstract][Full Text] [Related]
2. Thiazolidinedione treatment enhances insulin effects on protein kinase C-zeta /lambda activation and glucose transport in adipocytes of nondiabetic and Goto-Kakizaki type II diabetic rats.
Kanoh Y; Bandyopadhyay G; Sajan MP; Standaert ML; Farese RV
J Biol Chem; 2000 Jun; 275(22):16690-6. PubMed ID: 10749857
[TBL] [Abstract][Full Text] [Related]
3. Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise.
Beeson M; Sajan MP; Dizon M; Grebenev D; Gomez-Daspet J; Miura A; Kanoh Y; Powe J; Bandyopadhyay G; Standaert ML; Farese RV
Diabetes; 2003 Aug; 52(8):1926-34. PubMed ID: 12882907
[TBL] [Abstract][Full Text] [Related]
4. Cbl, IRS-1, and IRS-2 mediate effects of rosiglitazone on PI3K, PKC-lambda, and glucose transport in 3T3/L1 adipocytes.
Standaert ML; Kanoh Y; Sajan MP; Bandyopadhyay G; Farese RV
Endocrinology; 2002 May; 143(5):1705-16. PubMed ID: 11956152
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle insulin resistance in obesity-associated type 2 diabetes in monkeys is linked to a defect in insulin activation of protein kinase C-zeta/lambda/iota.
Standaert ML; Ortmeyer HK; Sajan MP; Kanoh Y; Bandyopadhyay G; Hansen BC; Farese RV
Diabetes; 2002 Oct; 51(10):2936-43. PubMed ID: 12351430
[TBL] [Abstract][Full Text] [Related]
6. Defective activation of atypical protein kinase C zeta and lambda by insulin and phosphatidylinositol-3,4,5-(PO4)(3) in skeletal muscle of rats following high-fat feeding and streptozotocin-induced diabetes.
Kanoh Y; Sajan MP; Bandyopadhyay G; Miura A; Standaert ML; Farese RV
Endocrinology; 2003 Mar; 144(3):947-54. PubMed ID: 12586772
[TBL] [Abstract][Full Text] [Related]
7. Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes.
Bandyopadhyay G; Standaert ML; Galloway L; Moscat J; Farese RV
Endocrinology; 1997 Nov; 138(11):4721-31. PubMed ID: 9348199
[TBL] [Abstract][Full Text] [Related]
8. Insulin-stimulated plasma membrane association and activation of Akt2, aPKC zeta and aPKC lambda in high fat fed rodent skeletal muscle.
Herr HJ; Bernard JR; Reeder DW; Rivas DA; Limon JJ; Yaspelkis BB
J Physiol; 2005 Jun; 565(Pt 2):627-36. PubMed ID: 15802290
[TBL] [Abstract][Full Text] [Related]
9. Knockout of PKC alpha enhances insulin signaling through PI3K.
Leitges M; Plomann M; Standaert ML; Bandyopadhyay G; Sajan MP; Kanoh Y; Farese RV
Mol Endocrinol; 2002 Apr; 16(4):847-58. PubMed ID: 11923480
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific differences in activation of atypical protein kinase C and protein kinase B in muscle, liver, and adipocytes of insulin receptor substrate-1 knockout mice.
Sajan MP; Standaert ML; Miura A; Kahn CR; Farese RV
Mol Endocrinol; 2004 Oct; 18(10):2513-21. PubMed ID: 15256535
[TBL] [Abstract][Full Text] [Related]
11. Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells.
Kausch C; Krützfeldt J; Witke A; Rettig A; Bachmann O; Rett K; Matthaei S; Machicao F; Häring HU; Stumvoll M
Biochem Biophys Res Commun; 2001 Jan; 280(3):664-74. PubMed ID: 11162573
[TBL] [Abstract][Full Text] [Related]
12. Alpha-lipoic acid mitigates insulin resistance in Goto-Kakizaki rats.
Bitar MS; Wahid S; Pilcher CW; Al-Saleh E; Al-Mulla F
Horm Metab Res; 2004 Aug; 36(8):542-9. PubMed ID: 15326564
[TBL] [Abstract][Full Text] [Related]
13. Impaired activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 in cultured preadipocyte-derived adipocytes and myotubes of obese subjects.
Sajan MP; Standaert ML; Miura A; Bandyopadhyay G; Vollenweider P; Franklin DM; Lea-Currie R; Farese RV
J Clin Endocrinol Metab; 2004 Aug; 89(8):3994-8. PubMed ID: 15292339
[TBL] [Abstract][Full Text] [Related]
14. Okadaic acid activates atypical protein kinase C (zeta/lambda) in rat and 3T3/L1 adipocytes. An apparent requirement for activation of Glut4 translocation and glucose transport.
Standaert ML; Bandyopadhyay G; Sajan MP; Cong L; Quon MJ; Farese RV
J Biol Chem; 1999 May; 274(20):14074-8. PubMed ID: 10318822
[TBL] [Abstract][Full Text] [Related]
15. Combined thiazolidinedione-metformin treatment synergistically improves insulin signalling to insulin receptor substrate-1-dependent phosphatidylinositol 3-kinase, atypical protein kinase C and protein kinase B/Akt in human diabetic muscle.
Temofonte N; Sajan MP; Nimal S; Pastoor T; Fumero C; Casaubon L; Powe JL; Standaert ML; Farese RV
Diabetologia; 2009 Jan; 52(1):60-4. PubMed ID: 18972094
[TBL] [Abstract][Full Text] [Related]
16. Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction.
Kim YB; Kotani K; Ciaraldi TP; Henry RR; Kahn BB
Diabetes; 2003 Aug; 52(8):1935-42. PubMed ID: 12882908
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone treatment increases protein kinase B phosphorylation in skeletal muscle of normoglycemic subjects at risk for the development of type 2 diabetes.
Meyer MM; Levin K; Grimmsmann T; Perwitz N; Eirich A; Beck-Nielsen H; Klein HH
Diabetes; 2002 Sep; 51(9):2691-7. PubMed ID: 12196460
[TBL] [Abstract][Full Text] [Related]
18. Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats.
Song XM; Kawano Y; Krook A; Ryder JW; Efendic S; Roth RA; Wallberg-Henriksson H; Zierath JR
Diabetes; 1999 Mar; 48(3):664-70. PubMed ID: 10078575
[TBL] [Abstract][Full Text] [Related]
19. Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C (zeta/lambda) activities.
Tremblay F; Lavigne C; Jacques H; Marette A
Diabetes; 2001 Aug; 50(8):1901-10. PubMed ID: 11473054
[TBL] [Abstract][Full Text] [Related]
20. Okadaic acid inhibits insulin-induced glucose transport in fetal brown adipocytes in an Akt-independent and protein kinase C zeta-dependent manner.
Valverde AM; Lorenzo M; Navarro P; Mur C; Benito M
FEBS Lett; 2000 Apr; 472(1):153-8. PubMed ID: 10781824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
